

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 7.73005608 |
| 2 | rhodopsin mediated signaling pathway (GO:0016056) | 7.55076639 |
| 3 | retinal cone cell development (GO:0046549) | 6.77262997 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.91895476 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.38286954 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.27374545 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.23130750 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.11360917 |
| 9 | photoreceptor cell maintenance (GO:0045494) | 5.01367966 |
| 10 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.01030947 |
| 11 | detection of light stimulus involved in visual perception (GO:0050908) | 5.01030947 |
| 12 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.00630452 |
| 13 | photoreceptor cell development (GO:0042461) | 4.99957790 |
| 14 | protein K11-linked deubiquitination (GO:0035871) | 4.93340417 |
| 15 | eye photoreceptor cell development (GO:0042462) | 4.77235249 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.77152214 |
| 17 | protein localization to synapse (GO:0035418) | 4.73159737 |
| 18 | glutamate secretion (GO:0014047) | 4.68987048 |
| 19 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 4.55882395 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51099415 |
| 21 | vocalization behavior (GO:0071625) | 4.49744262 |
| 22 | locomotory exploration behavior (GO:0035641) | 4.44926025 |
| 23 | phototransduction (GO:0007602) | 4.42978683 |
| 24 | protein-chromophore linkage (GO:0018298) | 4.42958557 |
| 25 | phototransduction, visible light (GO:0007603) | 4.29050365 |
| 26 | detection of light stimulus (GO:0009583) | 4.24529470 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.24235207 |
| 28 | detection of visible light (GO:0009584) | 4.22579464 |
| 29 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.20783413 |
| 30 | retinal rod cell development (GO:0046548) | 4.18178879 |
| 31 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.17834832 |
| 32 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.06005870 |
| 33 | righting reflex (GO:0060013) | 4.04686561 |
| 34 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.04490977 |
| 35 | regulation of synaptic vesicle transport (GO:1902803) | 4.02189123 |
| 36 | positive regulation of neurotransmitter transport (GO:0051590) | 3.87995261 |
| 37 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.84652817 |
| 38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.82629565 |
| 39 | neuronal ion channel clustering (GO:0045161) | 3.80206633 |
| 40 | regulation of guanylate cyclase activity (GO:0031282) | 3.75117771 |
| 41 | neuronal action potential propagation (GO:0019227) | 3.72987855 |
| 42 | neurotransmitter secretion (GO:0007269) | 3.71353299 |
| 43 | synaptic transmission, glutamatergic (GO:0035249) | 3.69390389 |
| 44 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.65791630 |
| 45 | membrane hyperpolarization (GO:0060081) | 3.65683035 |
| 46 | visual perception (GO:0007601) | 3.65544614 |
| 47 | positive regulation of membrane potential (GO:0045838) | 3.65476407 |
| 48 | neuron cell-cell adhesion (GO:0007158) | 3.65433487 |
| 49 | neuron-neuron synaptic transmission (GO:0007270) | 3.65130164 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.64286713 |
| 51 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.63067870 |
| 52 | sensory perception of light stimulus (GO:0050953) | 3.61493342 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.60695392 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.60256740 |
| 55 | tooth mineralization (GO:0034505) | 3.59017596 |
| 56 | serotonin metabolic process (GO:0042428) | 3.55986182 |
| 57 | response to histamine (GO:0034776) | 3.51707985 |
| 58 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.50362998 |
| 59 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.42383136 |
| 60 | regulation of neurotransmitter secretion (GO:0046928) | 3.40995360 |
| 61 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.39105379 |
| 62 | chemosensory behavior (GO:0007635) | 3.39001995 |
| 63 | exploration behavior (GO:0035640) | 3.36950003 |
| 64 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.36705447 |
| 65 | glutamate receptor signaling pathway (GO:0007215) | 3.34402596 |
| 66 | primary amino compound metabolic process (GO:1901160) | 3.33463220 |
| 67 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.32666894 |
| 68 | positive regulation of protein sumoylation (GO:0033235) | 3.32608921 |
| 69 | postsynaptic membrane organization (GO:0001941) | 3.30781430 |
| 70 | cAMP biosynthetic process (GO:0006171) | 3.29792169 |
| 71 | positive regulation of dendritic spine development (GO:0060999) | 3.29172815 |
| 72 | neurotransmitter transport (GO:0006836) | 3.27238292 |
| 73 | GMP metabolic process (GO:0046037) | 3.26493922 |
| 74 | long-term memory (GO:0007616) | 3.24860949 |
| 75 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.24833470 |
| 76 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24741006 |
| 77 | behavioral response to cocaine (GO:0048148) | 3.23906399 |
| 78 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.23378193 |
| 79 | transmission of nerve impulse (GO:0019226) | 3.22958619 |
| 80 | sodium ion export (GO:0071436) | 3.21486739 |
| 81 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.21222615 |
| 82 | reflex (GO:0060004) | 3.21004214 |
| 83 | behavioral response to nicotine (GO:0035095) | 3.20938588 |
| 84 | * potassium ion transmembrane transport (GO:0071805) | 3.20141862 |
| 85 | * cellular potassium ion transport (GO:0071804) | 3.20141862 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.19456304 |
| 87 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18931284 |
| 88 | detection of external stimulus (GO:0009581) | 3.16782182 |
| 89 | axon ensheathment in central nervous system (GO:0032291) | 3.15185353 |
| 90 | central nervous system myelination (GO:0022010) | 3.15185353 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.13911799 |
| 92 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.11094745 |
| 93 | detection of abiotic stimulus (GO:0009582) | 3.10732986 |
| 94 | dendritic spine morphogenesis (GO:0060997) | 3.09151690 |
| 95 | regulation of synapse structural plasticity (GO:0051823) | 3.09103868 |
| 96 | long-term synaptic potentiation (GO:0060291) | 3.08839166 |
| 97 | layer formation in cerebral cortex (GO:0021819) | 3.07930297 |
| 98 | eye photoreceptor cell differentiation (GO:0001754) | 3.07605706 |
| 99 | photoreceptor cell differentiation (GO:0046530) | 3.07605706 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 3.05242053 |
| 101 | membrane depolarization during action potential (GO:0086010) | 3.05053215 |
| 102 | innervation (GO:0060384) | 3.04603342 |
| 103 | seminiferous tubule development (GO:0072520) | 3.03912578 |
| 104 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03861831 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03861831 |
| 106 | gamma-aminobutyric acid transport (GO:0015812) | 3.03005601 |
| 107 | regulation of synaptic plasticity (GO:0048167) | 3.02917286 |
| 108 | neuromuscular synaptic transmission (GO:0007274) | 3.00798156 |
| 109 | cellular response to ATP (GO:0071318) | 3.00002985 |
| 110 | L-amino acid import (GO:0043092) | 2.99996750 |
| 111 | membrane depolarization (GO:0051899) | 2.97929677 |
| 112 | activation of protein kinase A activity (GO:0034199) | 2.97727506 |
| 113 | synaptic vesicle endocytosis (GO:0048488) | 2.95509956 |
| 114 | behavioral defense response (GO:0002209) | 2.95409237 |
| 115 | behavioral fear response (GO:0001662) | 2.95409237 |
| 116 | startle response (GO:0001964) | 2.94407067 |
| 117 | neuron recognition (GO:0008038) | 2.93205365 |
| 118 | neuromuscular process controlling posture (GO:0050884) | 2.91268774 |
| 119 | cellular response to light stimulus (GO:0071482) | 2.90980601 |
| 120 | striatum development (GO:0021756) | 2.90866130 |
| 121 | * potassium ion transport (GO:0006813) | 2.90646777 |
| 122 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.89796997 |
| 123 | dopamine receptor signaling pathway (GO:0007212) | 2.88098273 |
| 124 | cell communication by electrical coupling (GO:0010644) | 2.87457599 |
| 125 | regulation of neurotransmitter uptake (GO:0051580) | 2.87163676 |
| 126 | fear response (GO:0042596) | 2.86855110 |
| 127 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.86736764 |
| 128 | synaptic transmission, dopaminergic (GO:0001963) | 2.85935007 |
| 129 | behavioral response to ethanol (GO:0048149) | 2.84016090 |
| 130 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.83162185 |
| 131 | proline transport (GO:0015824) | 2.82344021 |
| 132 | retina layer formation (GO:0010842) | 2.81981846 |
| 133 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.81242149 |
| 134 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.81242149 |
| 135 | * synaptic transmission (GO:0007268) | 2.80854126 |
| 136 | regulation of dendritic spine development (GO:0060998) | 2.80803935 |
| 137 | dendritic spine organization (GO:0097061) | 2.79474429 |
| 138 | neural tube formation (GO:0001841) | 2.79401309 |
| 139 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.78948232 |
| 140 | cAMP metabolic process (GO:0046058) | 2.78946052 |
| 141 | response to auditory stimulus (GO:0010996) | 2.75488775 |
| 142 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.75445501 |
| 143 | neuronal action potential (GO:0019228) | 2.72399056 |
| 144 | indole-containing compound metabolic process (GO:0042430) | 2.70862947 |
| 145 | auditory behavior (GO:0031223) | 2.68314235 |
| 146 | enteric nervous system development (GO:0048484) | 2.65519503 |
| 147 | regulation of neurotransmitter levels (GO:0001505) | 2.60262709 |
| 148 | phosphorelay signal transduction system (GO:0000160) | 2.60115805 |
| 149 | response to dietary excess (GO:0002021) | 2.59881529 |
| 150 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.59803725 |
| 151 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.59671063 |
| 152 | regulation of cell communication by electrical coupling (GO:0010649) | 2.57073360 |
| 153 | indolalkylamine catabolic process (GO:0046218) | 2.56899010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.24493433 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75301582 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.91107072 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80634671 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68800123 |
| 6 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54872970 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54734885 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.52271319 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50993970 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50993970 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.47788214 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42450207 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39372235 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38573732 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36686559 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27315557 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.24659851 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17983106 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08391614 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08074623 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.06473393 |
| 22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98948555 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97391860 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97108756 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92072193 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85504417 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81939842 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79498898 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76353689 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71517217 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70331908 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69715196 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67706939 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65530871 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62354748 |
| 36 | TP53_16413492_ChIP-PET_HCT116_Human | 1.60195926 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54678359 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.54089485 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47869348 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41334148 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41177519 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37756080 |
| 43 | AR_19668381_ChIP-Seq_PC3_Human | 1.34896734 |
| 44 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.34125877 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33684183 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33257297 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31669387 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30861876 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30334194 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28673936 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27681724 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26197572 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26197572 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25997072 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25832165 |
| 56 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25649021 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25453868 |
| 58 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.23432427 |
| 59 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23290066 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22154298 |
| 61 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21113043 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21021612 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19796842 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19158877 |
| 65 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18818471 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18552376 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18494510 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18433478 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17475348 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16558113 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16165544 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15634438 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15260245 |
| 74 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14709161 |
| 75 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14612085 |
| 76 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14490324 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14282874 |
| 78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13876572 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12920911 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12600507 |
| 81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12523249 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12026388 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12011833 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11778188 |
| 85 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11247456 |
| 86 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10161034 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09675563 |
| 88 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09261696 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09078492 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08753373 |
| 91 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08734664 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08710519 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07705165 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07174057 |
| 95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05877230 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05430121 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04611277 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04318943 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04276008 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04263361 |
| 101 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03075575 |
| 102 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02666446 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01670720 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00778168 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00397714 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00175009 |
| 107 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00040234 |
| 108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99779721 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99671650 |
| 110 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98757168 |
| 111 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98294828 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97767370 |
| 113 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96567770 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95896298 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95639054 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94591521 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94591521 |
| 118 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94569200 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92861031 |
| 120 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91466348 |
| 121 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90928929 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90833401 |
| 123 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89825536 |
| 124 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89704297 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88561905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 5.33271927 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.09649614 |
| 3 | MP0003011_delayed_dark_adaptation | 4.66301061 |
| 4 | MP0003880_abnormal_central_pattern | 4.05460272 |
| 5 | MP0005253_abnormal_eye_physiology | 3.50302204 |
| 6 | MP0004270_analgesia | 3.47534860 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.33769244 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 3.30065699 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.06296919 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.97986829 |
| 11 | MP0009745_abnormal_behavioral_response | 2.76732949 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.71130924 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.68068027 |
| 14 | MP0002064_seizures | 2.61641747 |
| 15 | MP0002822_catalepsy | 2.55366394 |
| 16 | MP0009046_muscle_twitch | 2.51846005 |
| 17 | MP0001486_abnormal_startle_reflex | 2.36858068 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.35219610 |
| 19 | MP0002272_abnormal_nervous_system | 2.34025934 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.32787816 |
| 21 | MP0002090_abnormal_vision | 2.05407708 |
| 22 | MP0002229_neurodegeneration | 2.00205145 |
| 23 | MP0005195_abnormal_posterior_eye | 1.94567319 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.86554826 |
| 25 | MP0002736_abnormal_nociception_after | 1.86424852 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.81997487 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.76705633 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.75912566 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.70285579 |
| 30 | MP0001984_abnormal_olfaction | 1.69931859 |
| 31 | MP0002882_abnormal_neuron_morphology | 1.66321057 |
| 32 | MP0001970_abnormal_pain_threshold | 1.59218661 |
| 33 | MP0001324_abnormal_eye_pigmentation | 1.56020937 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.54742060 |
| 35 | MP0004924_abnormal_behavior | 1.54732794 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.54732794 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.53403740 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.52550769 |
| 39 | MP0008569_lethality_at_weaning | 1.49318122 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.44507666 |
| 41 | MP0003195_calcinosis | 1.44164989 |
| 42 | MP0001485_abnormal_pinna_reflex | 1.43433416 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.43109821 |
| 44 | MP0002752_abnormal_somatic_nervous | 1.42849667 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.42370662 |
| 46 | MP0005391_vision/eye_phenotype | 1.38175518 |
| 47 | MP0002184_abnormal_innervation | 1.35941733 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.35171448 |
| 49 | MP0004133_heterotaxia | 1.34913508 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.32053011 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.31005244 |
| 52 | MP0003879_abnormal_hair_cell | 1.30074517 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.28977487 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.27752084 |
| 55 | MP0002928_abnormal_bile_duct | 1.26710097 |
| 56 | MP0000751_myopathy | 1.26588453 |
| 57 | MP0004233_abnormal_muscle_weight | 1.26083460 |
| 58 | MP0000778_abnormal_nervous_system | 1.22532344 |
| 59 | MP0004215_abnormal_myocardial_fiber | 1.21112163 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 1.21111667 |
| 61 | MP0004885_abnormal_endolymph | 1.20703579 |
| 62 | MP0005448_abnormal_energy_balance | 1.18705636 |
| 63 | MP0003329_amyloid_beta_deposits | 1.17947493 |
| 64 | MP0004858_abnormal_nervous_system | 1.16270919 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.12673758 |
| 66 | MP0008877_abnormal_DNA_methylation | 1.11530652 |
| 67 | MP0004147_increased_porphyrin_level | 1.09755756 |
| 68 | MP0003633_abnormal_nervous_system | 1.09558703 |
| 69 | MP0000955_abnormal_spinal_cord | 1.06823145 |
| 70 | MP0003252_abnormal_bile_duct | 1.06598918 |
| 71 | MP0004085_abnormal_heartbeat | 1.00325765 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.00259541 |
| 73 | MP0003787_abnormal_imprinting | 0.99855298 |
| 74 | MP0010386_abnormal_urinary_bladder | 0.97478904 |
| 75 | MP0001905_abnormal_dopamine_level | 0.95314513 |
| 76 | MP0001529_abnormal_vocalization | 0.95229180 |
| 77 | MP0003646_muscle_fatigue | 0.91749811 |
| 78 | MP0003690_abnormal_glial_cell | 0.91740161 |
| 79 | MP0002653_abnormal_ependyma_morphology | 0.90397080 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 0.89376604 |
| 81 | MP0003632_abnormal_nervous_system | 0.88701844 |
| 82 | MP0001188_hyperpigmentation | 0.88513363 |
| 83 | MP0003631_nervous_system_phenotype | 0.86186501 |
| 84 | MP0004142_abnormal_muscle_tone | 0.86151231 |
| 85 | MP0003634_abnormal_glial_cell | 0.84658548 |
| 86 | MP0002152_abnormal_brain_morphology | 0.83485600 |
| 87 | MP0008872_abnormal_physiological_respon | 0.82981561 |
| 88 | MP0001963_abnormal_hearing_physiology | 0.80965564 |
| 89 | MP0003136_yellow_coat_color | 0.80671319 |
| 90 | MP0000920_abnormal_myelination | 0.80245132 |
| 91 | MP0005394_taste/olfaction_phenotype | 0.79799623 |
| 92 | MP0005499_abnormal_olfactory_system | 0.79799623 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.77953195 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.77085576 |
| 95 | MP0002102_abnormal_ear_morphology | 0.77021353 |
| 96 | MP0005535_abnormal_body_temperature | 0.75767795 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.73539346 |
| 98 | MP0002069_abnormal_eating/drinking_beha | 0.73292745 |
| 99 | MP0004742_abnormal_vestibular_system | 0.72691649 |
| 100 | MP0008874_decreased_physiological_sensi | 0.71109535 |
| 101 | MP0005620_abnormal_muscle_contractility | 0.70419011 |
| 102 | MP0005670_abnormal_white_adipose | 0.69292638 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.67570681 |
| 104 | MP0004484_altered_response_of | 0.67500143 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.67198811 |
| 106 | MP0002751_abnormal_autonomic_nervous | 0.66541522 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.64713835 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.64163096 |
| 109 | MP0003122_maternal_imprinting | 0.63627863 |
| 110 | MP0001177_atelectasis | 0.62875775 |
| 111 | MP0000427_abnormal_hair_cycle | 0.61909909 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.61663694 |
| 113 | MP0004043_abnormal_pH_regulation | 0.61532588 |
| 114 | MP0005187_abnormal_penis_morphology | 0.61455073 |
| 115 | MP0005171_absent_coat_pigmentation | 0.60476553 |
| 116 | MP0000749_muscle_degeneration | 0.59727124 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.59540895 |
| 118 | MP0003283_abnormal_digestive_organ | 0.59424362 |
| 119 | MP0001664_abnormal_digestion | 0.58892262 |
| 120 | MP0000026_abnormal_inner_ear | 0.58563878 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.58548214 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.58547229 |
| 123 | MP0004130_abnormal_muscle_cell | 0.58290893 |
| 124 | MP0003045_fibrosis | 0.57382513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 9.53843271 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 8.07811713 |
| 3 | Central scotoma (HP:0000603) | 7.41508490 |
| 4 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.68110749 |
| 5 | Dyschromatopsia (HP:0007641) | 6.62826939 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 6.53165790 |
| 7 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.43171991 |
| 8 | Scotoma (HP:0000575) | 6.23672204 |
| 9 | Focal motor seizures (HP:0011153) | 5.60557271 |
| 10 | Pigmentary retinal degeneration (HP:0001146) | 5.40680224 |
| 11 | Attenuation of retinal blood vessels (HP:0007843) | 5.17273392 |
| 12 | Chorioretinal atrophy (HP:0000533) | 4.89903369 |
| 13 | Decreased central vision (HP:0007663) | 4.67794962 |
| 14 | Pendular nystagmus (HP:0012043) | 4.63246864 |
| 15 | Myokymia (HP:0002411) | 4.53974656 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 4.29373248 |
| 17 | Focal seizures (HP:0007359) | 4.05258107 |
| 18 | Epileptic encephalopathy (HP:0200134) | 4.04481298 |
| 19 | Photophobia (HP:0000613) | 3.97410437 |
| 20 | Type II diabetes mellitus (HP:0005978) | 3.95182413 |
| 21 | Amelogenesis imperfecta (HP:0000705) | 3.89176074 |
| 22 | Febrile seizures (HP:0002373) | 3.86442018 |
| 23 | Choroideremia (HP:0001139) | 3.80295176 |
| 24 | Visual hallucinations (HP:0002367) | 3.75132386 |
| 25 | Abnormality of binocular vision (HP:0011514) | 3.64932400 |
| 26 | Diplopia (HP:0000651) | 3.64932400 |
| 27 | Severe visual impairment (HP:0001141) | 3.49109313 |
| 28 | Macular degeneration (HP:0000608) | 3.48291130 |
| 29 | Posterior subcapsular cataract (HP:0007787) | 3.42727499 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 3.35258588 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 3.35258588 |
| 32 | Progressive cerebellar ataxia (HP:0002073) | 3.28963677 |
| 33 | Polyuria (HP:0000103) | 3.25732478 |
| 34 | Retinitis pigmentosa (HP:0000510) | 3.18004238 |
| 35 | Overgrowth (HP:0001548) | 3.16295942 |
| 36 | Cone-rod dystrophy (HP:0000548) | 3.14388019 |
| 37 | Constricted visual fields (HP:0001133) | 3.12896829 |
| 38 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.10692489 |
| 39 | Atonic seizures (HP:0010819) | 3.10351981 |
| 40 | Protruding tongue (HP:0010808) | 3.09101170 |
| 41 | Inability to walk (HP:0002540) | 3.04554404 |
| 42 | Increased corneal curvature (HP:0100692) | 3.02486983 |
| 43 | Keratoconus (HP:0000563) | 3.02486983 |
| 44 | Nephronophthisis (HP:0000090) | 2.86923346 |
| 45 | Pancreatic cysts (HP:0001737) | 2.86317136 |
| 46 | Absence seizures (HP:0002121) | 2.85942791 |
| 47 | Broad-based gait (HP:0002136) | 2.84737762 |
| 48 | Clumsiness (HP:0002312) | 2.84640104 |
| 49 | Vitreoretinal degeneration (HP:0000655) | 2.82308455 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.79151966 |
| 51 | Hyperventilation (HP:0002883) | 2.74870689 |
| 52 | Generalized tonic-clonic seizures (HP:0002069) | 2.74380019 |
| 53 | Gaze-evoked nystagmus (HP:0000640) | 2.73646395 |
| 54 | Abnormal urine output (HP:0012590) | 2.68105053 |
| 55 | Action tremor (HP:0002345) | 2.65343416 |
| 56 | Hemiplegia (HP:0002301) | 2.60895175 |
| 57 | Dialeptic seizures (HP:0011146) | 2.59884725 |
| 58 | Truncal ataxia (HP:0002078) | 2.57810736 |
| 59 | Abnormality of the renal medulla (HP:0100957) | 2.55873191 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.53779686 |
| 61 | Retinal atrophy (HP:0001105) | 2.53592661 |
| 62 | Poor eye contact (HP:0000817) | 2.46490756 |
| 63 | Gait imbalance (HP:0002141) | 2.45191860 |
| 64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43992112 |
| 65 | True hermaphroditism (HP:0010459) | 2.40750341 |
| 66 | Abnormality of dental color (HP:0011073) | 2.39138072 |
| 67 | Genetic anticipation (HP:0003743) | 2.35409360 |
| 68 | Limb dystonia (HP:0002451) | 2.35270262 |
| 69 | Progressive visual loss (HP:0000529) | 2.32740657 |
| 70 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.32653067 |
| 71 | Widely spaced teeth (HP:0000687) | 2.30730443 |
| 72 | Fair hair (HP:0002286) | 2.28923866 |
| 73 | Congenital primary aphakia (HP:0007707) | 2.28125853 |
| 74 | Depression (HP:0000716) | 2.27531856 |
| 75 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.26531274 |
| 76 | Impaired social interactions (HP:0000735) | 2.25876781 |
| 77 | Abnormal social behavior (HP:0012433) | 2.25876781 |
| 78 | Abnormality of renal excretion (HP:0011036) | 2.22958559 |
| 79 | Abnormal drinking behavior (HP:0030082) | 2.20639747 |
| 80 | Polydipsia (HP:0001959) | 2.20639747 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.19830050 |
| 82 | Status epilepticus (HP:0002133) | 2.18630073 |
| 83 | Subcapsular cataract (HP:0000523) | 2.16408140 |
| 84 | Amblyopia (HP:0000646) | 2.15421892 |
| 85 | Optic disc pallor (HP:0000543) | 2.13484601 |
| 86 | Supranuclear gaze palsy (HP:0000605) | 2.12514723 |
| 87 | Dysmetric saccades (HP:0000641) | 2.11320350 |
| 88 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10152887 |
| 89 | Dysmetria (HP:0001310) | 2.10009835 |
| 90 | Chronic hepatic failure (HP:0100626) | 2.08796798 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08704304 |
| 92 | Horizontal nystagmus (HP:0000666) | 2.08570791 |
| 93 | Anxiety (HP:0000739) | 2.06474853 |
| 94 | Cystic liver disease (HP:0006706) | 2.06023275 |
| 95 | Impaired smooth pursuit (HP:0007772) | 2.04552179 |
| 96 | Progressive inability to walk (HP:0002505) | 2.02955630 |
| 97 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01559876 |
| 98 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.00589943 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 1.99659241 |
| 100 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.99582889 |
| 101 | Prolonged QT interval (HP:0001657) | 1.99491899 |
| 102 | Generalized hypopigmentation of hair (HP:0011358) | 1.97639553 |
| 103 | Postural instability (HP:0002172) | 1.97553005 |
| 104 | Scanning speech (HP:0002168) | 1.93026912 |
| 105 | Volvulus (HP:0002580) | 1.92884583 |
| 106 | Ankle clonus (HP:0011448) | 1.89648110 |
| 107 | Drooling (HP:0002307) | 1.89631299 |
| 108 | Excessive salivation (HP:0003781) | 1.89631299 |
| 109 | Abnormal EKG (HP:0003115) | 1.89428041 |
| 110 | Syncope (HP:0001279) | 1.89118499 |
| 111 | Abnormality of the renal cortex (HP:0011035) | 1.88951904 |
| 112 | Type II lissencephaly (HP:0007260) | 1.86515913 |
| 113 | Fetal akinesia sequence (HP:0001989) | 1.86260636 |
| 114 | Epileptiform EEG discharges (HP:0011182) | 1.85219908 |
| 115 | Pheochromocytoma (HP:0002666) | 1.83917543 |
| 116 | Absent speech (HP:0001344) | 1.83243456 |
| 117 | Wide nasal bridge (HP:0000431) | 1.82856574 |
| 118 | Tachypnea (HP:0002789) | 1.80666702 |
| 119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79070088 |
| 120 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.77951058 |
| 121 | Ventricular fibrillation (HP:0001663) | 1.75367911 |
| 122 | EEG with generalized epileptiform discharges (HP:0011198) | 1.74232568 |
| 123 | Abnormality of the dental pulp (HP:0006479) | 1.73089230 |
| 124 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.72830492 |
| 125 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.70621850 |
| 126 | Abnormality of alanine metabolism (HP:0010916) | 1.70621850 |
| 127 | Hyperalaninemia (HP:0003348) | 1.70621850 |
| 128 | Bradykinesia (HP:0002067) | 1.69783127 |
| 129 | Poor coordination (HP:0002370) | 1.69415555 |
| 130 | Genital tract atresia (HP:0001827) | 1.68675231 |
| 131 | Vaginal atresia (HP:0000148) | 1.68349013 |
| 132 | Dyskinesia (HP:0100660) | 1.68259316 |
| 133 | Spastic gait (HP:0002064) | 1.64961010 |
| 134 | Abnormality of salivation (HP:0100755) | 1.63563582 |
| 135 | Abnormality of renin-angiotensin system (HP:0000847) | 1.63549703 |
| 136 | Polyphagia (HP:0002591) | 1.63113655 |
| 137 | Abnormality of the lower motor neuron (HP:0002366) | 1.61601017 |
| 138 | Hypsarrhythmia (HP:0002521) | 1.61180255 |
| 139 | Hemiparesis (HP:0001269) | 1.59648683 |
| 140 | Impaired vibratory sensation (HP:0002495) | 1.59421464 |
| 141 | Specific learning disability (HP:0001328) | 1.59105976 |
| 142 | Stereotypic behavior (HP:0000733) | 1.58467030 |
| 143 | Abnormal eating behavior (HP:0100738) | 1.56857141 |
| 144 | Urinary urgency (HP:0000012) | 1.55291593 |
| 145 | Intention tremor (HP:0002080) | 1.54939487 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.54596485 |
| 147 | Generalized myoclonic seizures (HP:0002123) | 1.54289053 |
| 148 | Torticollis (HP:0000473) | 1.51417326 |
| 149 | Papilledema (HP:0001085) | 1.49661497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.15296075 |
| 2 | EPHA4 | 4.72052549 |
| 3 | NTRK3 | 4.34267489 |
| 4 | GRK1 | 3.24012696 |
| 5 | MAP3K9 | 3.13649186 |
| 6 | MAP3K4 | 3.08746121 |
| 7 | MAP2K7 | 2.46881303 |
| 8 | DAPK2 | 2.46783948 |
| 9 | PRKD3 | 2.19158185 |
| 10 | MINK1 | 2.16934977 |
| 11 | ACVR1B | 2.12274327 |
| 12 | MARK1 | 2.10342408 |
| 13 | PAK6 | 2.10264952 |
| 14 | CASK | 2.04367990 |
| 15 | BMPR1B | 2.04234379 |
| 16 | RIPK4 | 1.87280255 |
| 17 | MAP2K4 | 1.84589637 |
| 18 | CAMKK1 | 1.78264754 |
| 19 | SIK2 | 1.77937839 |
| 20 | ADRBK2 | 1.72502322 |
| 21 | KSR2 | 1.70517883 |
| 22 | NTRK1 | 1.64877589 |
| 23 | PINK1 | 1.59372723 |
| 24 | NTRK2 | 1.53042809 |
| 25 | PNCK | 1.50216818 |
| 26 | CDK5 | 1.49278147 |
| 27 | STK38 | 1.47647941 |
| 28 | DAPK1 | 1.46955216 |
| 29 | GRK5 | 1.44633289 |
| 30 | PLK2 | 1.44104417 |
| 31 | MAP3K12 | 1.33350163 |
| 32 | FES | 1.33124085 |
| 33 | KSR1 | 1.24868520 |
| 34 | BLK | 1.24173109 |
| 35 | PRPF4B | 1.17914407 |
| 36 | SGK223 | 1.15998508 |
| 37 | SGK494 | 1.15998508 |
| 38 | SGK2 | 1.15027340 |
| 39 | MAPK13 | 1.11674509 |
| 40 | CAMK1G | 1.11495511 |
| 41 | PRKCG | 1.11400849 |
| 42 | WNK3 | 1.10249194 |
| 43 | MAP3K2 | 1.10170703 |
| 44 | TNIK | 1.10142301 |
| 45 | STK3 | 1.05358971 |
| 46 | CDK19 | 1.04375473 |
| 47 | PHKG1 | 1.02972779 |
| 48 | PHKG2 | 1.02972779 |
| 49 | PRKCH | 1.02758990 |
| 50 | CAMK2A | 1.02022993 |
| 51 | OBSCN | 1.00706104 |
| 52 | CAMK1 | 0.98618386 |
| 53 | WNK4 | 0.97845103 |
| 54 | SGK3 | 0.95868160 |
| 55 | AKT3 | 0.92514571 |
| 56 | CAMKK2 | 0.91510852 |
| 57 | STK39 | 0.90202910 |
| 58 | STK11 | 0.86115175 |
| 59 | BMPR2 | 0.84006367 |
| 60 | SGK1 | 0.83609591 |
| 61 | INSRR | 0.83274916 |
| 62 | ARAF | 0.82969200 |
| 63 | CAMK2D | 0.82936279 |
| 64 | PIK3CA | 0.81602894 |
| 65 | UHMK1 | 0.79398262 |
| 66 | TAOK1 | 0.79142391 |
| 67 | RET | 0.79137766 |
| 68 | MAP4K2 | 0.78328460 |
| 69 | MAPK12 | 0.78003968 |
| 70 | MAP3K13 | 0.76990744 |
| 71 | LMTK2 | 0.75069467 |
| 72 | PTK2B | 0.74756281 |
| 73 | CAMK2B | 0.74580091 |
| 74 | PKN1 | 0.74358377 |
| 75 | TLK1 | 0.72540787 |
| 76 | ADRBK1 | 0.71958379 |
| 77 | MKNK2 | 0.71411670 |
| 78 | WNK1 | 0.69523182 |
| 79 | CDK18 | 0.68315816 |
| 80 | MAPK7 | 0.67772279 |
| 81 | PRKAA1 | 0.66493290 |
| 82 | CDK15 | 0.66323718 |
| 83 | MAP2K6 | 0.65471119 |
| 84 | PDK1 | 0.65191981 |
| 85 | CCNB1 | 0.64925864 |
| 86 | STK38L | 0.64383500 |
| 87 | DYRK1A | 0.62442599 |
| 88 | CDC42BPA | 0.62214742 |
| 89 | PAK3 | 0.62168982 |
| 90 | CDK14 | 0.61851945 |
| 91 | MAP4K1 | 0.61770956 |
| 92 | FGFR2 | 0.61474640 |
| 93 | TAOK3 | 0.61152628 |
| 94 | PDPK1 | 0.60535593 |
| 95 | RPS6KA3 | 0.60534610 |
| 96 | PRKCZ | 0.60263303 |
| 97 | MUSK | 0.59800821 |
| 98 | TYRO3 | 0.57993891 |
| 99 | TNK2 | 0.57382453 |
| 100 | MARK2 | 0.56703284 |
| 101 | CAMK4 | 0.56157461 |
| 102 | CDK11A | 0.55932985 |
| 103 | ZAK | 0.55226966 |
| 104 | MAP3K1 | 0.55033441 |
| 105 | PRKCE | 0.54484712 |
| 106 | FER | 0.54004035 |
| 107 | MAP3K7 | 0.53505064 |
| 108 | OXSR1 | 0.52827106 |
| 109 | NUAK1 | 0.52167163 |
| 110 | PRKCB | 0.51174447 |
| 111 | PIK3CG | 0.50709698 |
| 112 | RAF1 | 0.49227097 |
| 113 | MAPK10 | 0.48639002 |
| 114 | MAP3K6 | 0.46864120 |
| 115 | SIK3 | 0.46698192 |
| 116 | MAPKAPK5 | 0.46550341 |
| 117 | CAMK1D | 0.46386036 |
| 118 | PRKAA2 | 0.46312106 |
| 119 | ERBB2 | 0.44676798 |
| 120 | PRKG1 | 0.44296287 |
| 121 | CSNK1G2 | 0.43427006 |
| 122 | NEK6 | 0.42944274 |
| 123 | PRKD2 | 0.42914584 |
| 124 | NME1 | 0.42790096 |
| 125 | PRKCA | 0.42733093 |
| 126 | TXK | 0.42585762 |
| 127 | HIPK2 | 0.41209872 |
| 128 | CAMK2G | 0.40523428 |
| 129 | MAPK15 | 0.39914387 |
| 130 | PRKACA | 0.38733874 |
| 131 | ALK | 0.38645040 |
| 132 | LATS2 | 0.38274849 |
| 133 | CSNK1A1 | 0.37077811 |
| 134 | CSNK1D | 0.36941824 |
| 135 | PRKCQ | 0.36923146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 8.49546581 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.04949301 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.78558892 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.76116231 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36376429 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.34414642 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.28297189 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.21660922 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.17629300 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13006910 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.98804816 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.94009036 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.93974362 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.83359679 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83278332 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82540556 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.81071101 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.74552097 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57794836 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53315994 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52094433 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49811745 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.47994201 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47792029 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.42478510 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.40287284 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33706662 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23084299 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22539310 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17587337 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.17232543 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15408512 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14452941 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11539236 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10110780 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09697713 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09062961 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08902961 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03706127 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.03558329 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02271677 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02218859 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97903707 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93564870 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 0.92003929 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88303708 |
| 47 | Glioma_Homo sapiens_hsa05214 | 0.83073152 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82196645 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80510731 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79834016 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79435915 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78079945 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75520419 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.75364472 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.75022808 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73640300 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67378467 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.66440781 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65018656 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63534481 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62128768 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62083490 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61897076 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61659238 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61088119 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60920686 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60765699 |
| 68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59058788 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57734529 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57666344 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57360639 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55012650 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54480949 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54285441 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53086525 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.51038528 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50964424 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50800683 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50069173 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46479346 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46192751 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45421291 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44967536 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44016608 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43741385 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42842524 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42720155 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41659690 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41030926 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40082996 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39198573 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38589809 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.38356493 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36415449 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.35664929 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35045523 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34310396 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33653936 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32938457 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31350627 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31260699 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30900612 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30498091 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30497531 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30441094 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28564270 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.28506987 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27788762 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27755778 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26969130 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26926047 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26882776 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.26443306 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26269129 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26196257 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25800587 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.25728559 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25315469 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24160734 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23974917 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23498111 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23055201 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22737776 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21178822 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20770092 |
| 126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20590647 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20167002 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18828314 |

